Arkolith/Insider Trading/ANIK/Form 4

Thompson Jeffery S

DirectorAnika Therapeutics, Inc. (ANIK) · full profile →Form 4 · filed Mar 15, 2022
Net Buying
Open-Market Buys
$49K
Open-Market Sells
$0
Net Open-Market Flow
$49K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2022Buy(P)2K$24.66$49K17K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-22-001878) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML